Arrowhead Pharmaceuticals Inc.

(ARWR) Trade

By |

Profile

Arrowhead Pharmaceuticals Inc is engaged in developing novel drugs to treat intractable diseases by silencing the genes. The Company\'s drug candidate ARC-520 is designed to treat chronic hepatitis B infection.

Contact Information

Website: www.arrowheadpharma.com
Email: ir@arrowres.com
Main Phone: +1 626 304-3400
Address: 225 South Lake Avenue
Address 2: Suite 1050
State: CA
City / Town: Pasedena
Country: USA
Postal Code: 91101

Issuer Information

Exchange: NGS
Employees: 104
NAICS: 541711
$ 1.55 $ -0.01 (-0.64%)
Last Price 1.55 Change $ -0.01 Change % -0.64 Tick N/A
Bid 1.50 Bid Size 1,000.00 Ask 1.98 Ask Size 2,000.00
Open 1.57 High 1.59 Low 1.50 Prev Close 1.56
Last Trade Volume 641,047 52 Wk Hi 8.22 52 Wk Low 1.20
Market Cap 115.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 74,569,706.00 EPS (TTM) -1.18 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 16
Number of Buys 2 8
Number of Sells 1 8
Net Activity 8517 692350
Last 10 Buys Shares
Christopher Anzalone 1,000
Christopher Anzalone 1,000
Mauro Ferrari 1,000
Mauro Ferrari 1,000
Christopher Anzalone 1,000
Kenneth Myszkowski 1,000
Christopher Anzalone 1,000
Last 10 Sell Shares
Kenneth Myszkowski 1,000
David L. Lewis 1,000
Charles P. McKenney 1,000
Kenneth Myszkowski 1,000
Charles P. McKenney 1,000
Edward W. Frykman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 5.5 4.75 4.75 5.5
Mean Target Price Estimate 11.38 11.19 11.19 10.75
Standard Deviation 4.11 4.47 4.47 3.9
Date of Most Recent Estimate 08/10/16 05/20/16 05/20/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.4 1.67 1.67 1.67